Viewing nowAtorix Tablet 20 mg (Atorvastatin Calcium Hydrate)
Atorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

MFDS item code 201406140 · Approved 2014.12.30 · Insurance code 669804560
Improvement of hyperlipidemia (including in children); prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)
This medicine helps reduce the risk of cardiovascular diseases. It particularly reduces the risk of cardiovascular events such as myocardial infarction, stroke, vascular interventions, and angina in adults with risk factors for coronary heart disease and in patients with type 2 diabetes. For patients with existing coronary heart disease, it reduces the risk of myocardial infarction, stroke, vascular interventions, hospitalizations for congestive heart failure, and angina. Additionally, it helps patients with hyperlipidemia maintain a healthy lipid profile by reducing total cholesterol, LDL cholesterol, Apo-B protein, and triglyceride levels while increasing HDL cholesterol levels. It is also effective as an adjunct to dietary therapy for familial hypercholesterolemia in children and adolescents, improving dangerous cholesterol levels. Therefore, this medication is used for the prevention of cardiovascular diseases and the treatment of hyperlipidemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is atorvastatin 10 mg once daily; however, for patients who require a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered in a dosage range of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient’s characteristics, taking into consideration the treatment goal and response. Lipid levels should be analyzed 2 ~ 4 weeks after treatment initiation and/or dose titration, and the dose adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol levels may be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration or LDL cholesterol-lowering effect of atorvastatin; therefore, no dosage adjustment is necessary. ○ Elderly patients: The efficacy and safety in patients aged 70 years and older are generally similar to those in the usual adult patient population.
2. Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose of this medicine is 10 mg once daily, and the recommended maximum dose is 20 mg per day (there are no clinical data on administration of doses higher than 20 mg in pediatric patients). Adjust the dose as appropriate according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer.
This medication may cause serious muscle-related side effects such as myopathy or rhabdomyolysis, so if symptoms like muscle pain or weakness occur, immediately inform your healthcare provider. Do not use this medication in patients with specific liver diseases or serious liver insufficiency; if symptoms of liver dysfunction occur, stop taking the medication and consult a physician. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication and fertile women should use appropriate contraception during treatment. Children under 10 years of age, patients with muscle diseases, and those taking certain medications (e.g., Glecaprevir, Pibrentasvir) should not use this medication. Patients with a history of alcoholism or liver disease, those with impaired kidney function, and elderly patients need to exercise greater caution when using this medication and should consult healthcare providers if muscle pain or abnormal symptoms arise. This medication can interact with various other drugs, so inform your doctor or pharmacist if you are taking any other medications, particularly when taking CYP3A4 inhibitors, cyclosporine, HIV protease inhibitors, and certain antibiotics and antifungals. During treatment with this medication, regular liver function tests and, if necessary, muscle-related tests should be conducted to check for abnormalities. In the case of overdose, there is no specific antidote, and treatment should be symptomatic while closely monitoring liver function and muscle enzyme levels. Finally, this medication should be kept out of reach of children and stored in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. The storage temperature should ideally be maintained at room temperature between 1 to 30 degrees Celsius. This helps preserve the effectiveness of the medication over time.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.